Although Cystatin C is a sensitive indicator of renal function, high levels of Cystatin C are an independent and significant predictor of END in elderly AIS patients with normal renal function in a Korean clinical study (Kim et al., 2017). This evidence concerns the gene CST3 and androgen insensitivity syndrome.